Pepticker
§ Related · Different goals

MOTS-c vs Tirzepatide

Related research areas, distinct mechanisms. Live $/mg pricing across every tracked vendor.

Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.

MOTS-c
27
vendors tracked
from $1.80/mg
Tirzepatide
10
vendors tracked
from $2.08/mg
How they overlap

Both surface in metabolic-research conversations — particularly around insulin sensitivity, weight regulation, and obesity-adjacent endpoints.

How they differ

Tirzepatide is a dual GLP-1/GIP agonist with strong clinical weight-loss data. MOTS-c is a 16-residue mitochondrial peptide studied as an exercise mimetic. The mechanisms don't overlap — these are not substitute compounds.

MOTS-c

Mitochondrial exerkine

Operational
$49.99
$10.00/mg
Out of stock◎ Best $/mg
Buy with code →
Sort:
2026-06-11

Tirzepatide

Dual GLP-1/GIP agonist

Operational
$24.00
$2.40/mg
In stock◎ Best $/mg
Buy with code →
Operational
$67.49
$6.75/mg
In stockOn sale181.2% vs best
Visit →
Operational
$99.00
$9.90/mg
In stock312.5% vs best
Visit →
$99.99
$10.00/mg
Out of stock316.6% vs best
Visit →
Operational
$199.99
$20.00/mg
In stock733.3% vs best
Visit →
$340.19
$34.02/mg
In stock1317.5% vs best
Visit →
Sort:
2026-06-18

About MOTS-c

A 16-residue peptide encoded within the mitochondrial 12S rRNA. Studied as an exercise-mimetic exerkine for metabolic health and longevity.

About Tirzepatide

A once-weekly dual GIP and GLP-1 receptor agonist studied for type-2 diabetes and obesity. Approved clinically in many jurisdictions; research-compound form is widely distributed.